Eli Lilly gained 2.7% as Morgan Stanley kept its positive rating, but the story gives no new business results or deal terms. It reports trading activity, not a change to Lilly’s business outlook.
The rating and deal mention do not show a new change in Lilly’s sales, profit, or deal terms. The article also says health care stocks rose as the wider market fell, describing trading rather than a change in Lilly’s business.
Helen of Troy is listed among companies expected to report results, but the story gives no results or company news. It does not change the company’s outlook.
PepsiCo is listed among companies expected to report results, but the story gives no results or company news. It does not change the company’s outlook.
Tilray is listed among companies expected to report results, but the story gives no results or company news. It does not change the company’s outlook.
Follow Eli Lilly and Co. (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LLY